Evidence map›Paper›PMID 41563609›Full record

ReviewCurrent osteoporosis reports2026

Current Status of AI-Assisted Screening for Opportunistic Osteoporosis.

Xiaoling Zheng, Zhangsheng Dai, Kaibin Fang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current osteoporosis reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiaoling ZhengLiming Vocational University, Quanzhou, 362000, China.
Zhangsheng DaiDepartment of Sports Medicine, The Second Affiliated Hospital of Fujian Medical University, No.34, Zhongshanbeilu, Quanzhou, Fujian, 362000, China.
Kaibin FangDepartment of Sports Medicine, The Second Affiliated Hospital of Fujian Medical University, No.34, Zhongshanbeilu, Quanzhou, Fujian, 362000, China. cffkb00@fjmu.edu.cn.

Funding

Fujian provincial health technology project 2020CXA045Fujian Provincial Science and Technology Innovation Joint Project Plan 2024Y9349research Fund for PhD Tutorship of the Second Affiliated Hospital of Fujian Medical University 2022BD0301
6 · The paper itself

Abstract

purpose of reviewThis review aims to summarise the current application and development trends of artificial intelligence in opportunistic screening for osteoporosis, with a focus on its potential to improve early detection and management of the disease. RECENT

findingsRecent advancements in AI, including radiomics, deep learning, and transfer learning, have significantly enhanced the efficacy of opportunistic screening for osteoporosis. Imaging modalities such as chest X-rays, lumbar X-rays, chest CT, hip joint CT, PET-CT, and lumbar magnetic resonance imaging have been successfully integrated into AI-driven screening protocols. These technologies have demonstrated acceptable efficacy in detecting osteoporosis, with the potential to increase the probability of identifying at-risk individuals. The evolution of image processing and segmentation techniques further supports the prospect of achieving fully automated AI-based opportunistic screening in the near future. The integration of AI into opportunistic screening for osteoporosis shows promise in improving early detection rates, particularly in aging populations. Achieving automatic segmentation of Region of Interest areas based on common medical imaging is a critical step in enabling opportunistic osteoporosis screening using artificial intelligence.

Indexed as

Artificial IntelligenceMass ScreeningOsteoporosisDeep LearningEarly DiagnosisHumansIntelligent SystemsMagnetic Resonance ImagingRadiomicsTomography, X-Ray ComputedArtificial intelligenceDeep learningOpportunistic screeningOsteoporosisRadiomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.